Abstract. Cardiac arrest (CA) is a leading cause of mortality worldwide. The majority of the associated mortalities are caused by post-CA syndrome, which includes symptoms, such as neurologic damage, myocardial dysfunction and systemic inflammation. Following CA, return of spontaneous circulation (ROSC) leads to a brain reperfusion injury, which subsequently causes adverse neurologic outcomes or mortality. Therefore, investigating the underlying mechanisms of ROSC-induced neurologic deficits and establishing potential treatments is critical to prevent and treat post-CA syndrome. In the current study, CA rat models were established by asphyxia. Following ROSC, the temperature was controlled to achieve hypothermia. The general neurologic status was assessed using the neurologic deficit scale. Changes in the concentrations of interleukin (IL)-18 and IL-1β were measured with ELISA and the dynamic change in NACHT, LRR and PYD domains-containing protein 3 inflammasome components was determined by western blot analysis and immunohistochemistry. Neuronal death and apoptosis were measured via TUNEL assays. In the CA rat models, increasing the duration of CA before cardiopulmonary resuscitation was found to aggravate the neural deficit and increase the incidence of inflammation. Following ROSC, the expression level of the inflammasome components was observed to increase in CA rat models, which was accompanied by increased secretion of IL-18 and IL-1β, indicating the promotion of inflammation. In addition, the study identified the beneficial role of spontaneous hypothermia in ameliorating the ROSC-induced inflammation and neurologic deficit in CA rat models, including the downregulation of inflammasome components and attenuating neuronal apoptosis. The present study contributes to the understanding of underlying mechanisms in CA-evoked inflammation and the subsequent neurologic damage following ROSC. A novel potential therapeutic strategy that may increase survival times and the quality of life for patients suffering from post-CA syndrome is proposed in the present study.
Introduction
Cardiac arrest (CA), also termed cardiopulmonary arrest, is a sudden stop in effective blood circulation, due to the failure of the heart to effectively contract or to contract at all. CA remains a major public health issue and is the most common direct cause of mortality in Western and developing countries (1, 2) . Overall survival of cardiac arrest patients outside of a hospital setting is only ~6.4% (3) . This low rate is due to the initial difficulty in restoring hemodynamic stability (4) , as well as to a high incidence of severe neurologic deficits caused by the CA (5) . Therefore, <30% of survivors are able to return to a normal functioning lifestyle (6) . The brain injury that results from the return of spontaneous circulation (ROSC) is a complicated process. The overall mechanisms remain elusive, but include altered Ca 2+ homeostasis, free radical formation, mitochondrial dysfunction, protease activation, altered gene expression and inflammation (7, 8) . These then lead to neuronal death in the central nervous system. Among all the potential mechanisms, inflammation stands out, as it is correlated with postischemic neuronal apoptosis (9) . NACHT, LRR, and PYD domains-containing protein 3 (NLRP3), a component of the inflammasome, has been reported to function as a pathogen recognition receptor that recognizes pathogen-associated molecular patterns (10, 11) . The inflammasome complex is a central component of the innate immune response via regulation of interleukin (IL)-1β, IL-18 and pyroptosis (12) . NLPR3 is significant in ischemia-reperfusion injuries in many tissue types, including renal (13), brain (14) and spinal cord (15 NLRP3-inflammasome induces the processing and release of IL-1β and IL-18 (16) . Deletion of NLRP3 may ameliorate the neurovascular damage in ischemic stroke mice (17) . Therefore, ischemic neural deficits caused by CA may also be mitigated via inhibition of NLRP3. Hypothermia is defined as a body core temperature <35.0˚C and has been known to be a potent putative neuroprotectant (18) . Mild hypothermia (33˚C) inhibits ischemia-induced promotion of mitochondrial membrane permeability, which may provide neuroprotection against cerebral injury following CA (19) . Spontaneous hypothermia (SH) is clinically associated with the risk of mortality (20) . Hickey et al (21) demonstrated that rats resuscitated from asphyxial CA developed neuroprotective SH (21) . However, whether the neural deficit resulting from CA was correlated with activation of the inflammasome and was ameliorated by SH remains unclear. In the present study, the neural damage alterations and inflammasome component expression levels were elucidated following ROSC in established CA rat models. In addition, the role of SH in the inhibition of inflammasome component expression, and the amelioration of the neurologic deficit and neuronal death in the cerebral cortex were determined. The aim of the present study was to investigate the underlying mechanisms of ROSC-induced neurological deficits, and assess the potential strategies for the prevention and treatment of post-CA syndrome.
Materials and methods
Grouping. In total, 84 male specific pathogen-free grade Sprague Dawley rats (weight, 350-400 g; age, 8 weeks) were purchased from the Laboratory Animal Center of Guangzhou University of Chinese Medicine (Guangzhou, China). Firstly, 18 rats were randomly separated into three groups as follows: Group I, control group; Group II, the CA model group that received cardiopulmonary resuscitation (CPR) 4 min after CA; and Group III, the CA model group, which received CPR 6 min after CA. Secondly, 36 rats were then randomly separated into two groups, including 6 control rats and 30 CA model rats. CPR was conducted 6 min after CA. The CA rats were equally sub-divided into five groups, according to the different time points (6, 12, 24, 48 and 72 h) after ROSC. Thirdly, 30 rats were randomly divided into two groups, including six control rats and 24 CA model rats. These CA rats were equally sub-divided into SH group and controlled normothermia (CN) group. The SH and CN groups were again divided into two, determined by 24 h (SH Group I and CN Group I) or 48 h (SH Group II and CN Group II) after ROSC. The mortality rate of rats during the preparation of rat models was 6.7%. The present study was approved by the ethics committee of Sun Yat-Sen University (Guangzhou, China).
CA rat model. Rat CA and resuscitation were performed, as previously described (21, 22) . Anesthesia was achieved using 45 mg/kg pentobarbital sodium. Animals were ventilated with a Harvard Rodent Ventilator (Harvard Apparatus, Holliston, MA, USA), and the temperature was measured and maintained at 37±0.5˚C throughout the preparation, insult, and first hour of recovery. Prior to asphyxia, the anesthetic gases were washed out with 3 min of ventilation at 100% oxygen, followed by 2 min of room air. Vecuronium was administered prior to asphyxia, in order to prevent reflex respiratory efforts during asphyxia. Subsequent to the washout period, animals were asphyxiated by disconnecting the respiratory tubing from the ventilator for 6 min, resulting in ~5 min of CA.
Resuscitation. Following exactly 5 min, the ventilator was reconnected and ventilation was resumed with oxygen at a rate of 60 breaths/min. Intravenous epinephrine (0.005 mg/kg) and bicarbonate (1.0 mEq/kg) were administered, and external chest compressions were performed at a rate of 250-300 compressions/min. Rats generally experienced a ROSC within 2 min. If not, an additional dose of epinephrine was administered. Following stabilization for at least 60 min and confirmation of adequate spontaneous respirations, rats were extubated and weaned from oxygen back to room air.
Temperature control. In the CN group, rats were maintained at 37±0.5˚C during CA and for 4 h after resuscitation. In the SH group, rats were maintained at 37˚C during CA, but following resuscitation were allowed to regulate their own temperature.
Neurologic deficit scale (NDS) score measurement. General neurologic status was assessed using the validated NDS at 24, 48, and 72 h after CA (23) . The score includes an assessment of consciousness, respiration, cranial nerve activity, motor and sensory function, and coordination. Normal rats have an NDS of zero.
Enzyme-linked immunosorbent assay (ELISA)
. Arterial blood samples (10 ml) were drawn at different time points after ROSC. Concentration changes in serum S100 calcium-binding protein B [S100B; cat. no. H6-KA0037, Multi Sciences (Lianke) Biotech Co., Ltd., Hangzhou, China], IL-1β [cat. no. 70-EK201B1/2, Multi Sciences (Lianke) Biotech Co., Ltd.] and IL-18 (cat. no. RK-KOA0362; Rockland Immunochemicals, Inc., Limerick, PA, USA) in the cerebral cortex were monitored by ELISA for the different groups. After coating with coating buffer (50 mmol/l sodium carbonate buffer, pH=9.6), plates were sequentially washed with phosphate buffered saline with 0.05% Tween-20 (PBST) buffer (cat. no. A100235-0001; Sangon Biotech Co., Ltd., Shanghai, China), blocked with 1% bovine serum albumin (BSA; cat. no. A602440-0050, Sangon Biotech Co., Ltd.), and incubated for 1 h at 37˚C. Anti-S100B (1:200), anti-IL-1β (1:200) or anti-IL-18 antibodies (1:100), and horseradish peroxidase-conjugated antibody (1:1,000; all included in the corresponding ELISA kit) were sequentially added and incubated for 1 h at 37˚C. The chromogenic substrate 3,3' ,5,5'-Tetramethylbenzidine was added for detection. Absorbance was measured at a wavelength of 450 nm using an EnSpire multimode plate reader (Perkin Elmer, Waltham, Massachusetts).
Western blotting. Tissue samples were lysed in radioimmunoprecipitation buffer (50 mM Tris-HCl buffer pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40 and 0.25% sodium deoxycholate). Total protein was extracted from tissue lysate by centrifugation at 12,000 x g for 10 min at 4˚C and protein concentrations were measured using a Bicinchoninic Acid assay (Sangon Biotech Co., Ltd.) according to the manufacturer's instructions. A total of 2 µg protein was loaded onto each lane of 10% polyacrylamide gel (250V voltage for 2 h) and blotted onto a polyvinylidene difluoride (PVDF) membrane. After blocking with PBST containing 5% nonfat dry milk, the membrane was incubated with antibodies against NLRP3 (cat. no. 13158; 1:500), apoptosis-associated speck-like protein containing a CARD (ASC; cat. no. 67824; 1:500), caspase-1 (cat. no. 2225; 1:400), caspase-3 (cat. no. 9662; 1:500), and β-tubulin (cat. no. 2146; 1:500; all Cell Signaling Technology, Inc., Danvers, MA, USA). Peroxidase-linked anti rabbit IgG (Thermo Fisher Scientific, Inc., Waltham, MA, USA) served as a secondary antibody. These proteins were visualized using an ECL western blotting detection kit (GE Healthcare, Chicago, IL, USA).
Immunohistochemistry. The rats were anesthetized with an overdose of 150 mg/kg pentobarbital and then sacrificed. The whole brain was immediately removed and frozen on dry ice. Then, the cerebral cortex site was separated from the whole brain. The sections of the cerebral cortex (~1.5 cm 3 ) were sequentially washed in dimethylbenzene and ethanol, before being blocked in 3% H 2 O 2 . All nonspecific binding sites were blocked for 30 min in PBS with 5% BSA. The sections were then incubated at 4˚C with anti-NLRP3, anti-ASC, anti-caspase-1, or anti-caspase-3 antibodies (Cell Signaling Technology, Inc.) overnight. Biotin-conjugated secondary antibody (cat. no. ab97044; Abcam, Cambridge, MA, USA) was applied to the slides and incubated for 1 h at room temperature. Finally, 3,3'-diaminobenzidine (DAB)/H 2 O 2 was added to the surface of the slide to develop the color at room temperature for 10 min. The slides were visualized using a Nikon ECLIPSE 90i.
TUNEL assay. Sections were perfused with dimethylbenzene and sequentially washed with different concentrations of ethanol and blocked in 3% H 2 O 2 . These sections were incubated in 5% BSA for 30 min and the fragmented DNA was labeled with the TUNEL reaction solution at 37˚C for 1 h. Converter-peroxidase was added to the sections at 37˚C for 30 min before the TUNEL-positive nuclei were visualized by adding the DAB staining solution. All images were captured using a Nikon ECLIPSE 90i.
Statistical analysis. Data are presented as means ± standard error of the mean and analysis was performed with GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA). The normalized intensity for western blotting bands was measured with Image J software version 1.45 (National Institutes of Health, Bethesda, MD, USA). Unpaired Student's t-tests and one-way ANOVA with a Tukey post hoc test were used to determine significant differences. P<0.05 was considered to indicate a statistically significant difference.
Results
Increasing duration of CA aggravated neural defects. In order to elucidate the role of CA in neural defects, physiological parameters were compared between the control group and the two asphyxia groups, determining that there was no significant difference in physiological parameters among the three groups (Table I) . Similarly, no apparent alteration in the majority of physiological parameters was observed between the two asphyxia groups following resuscitation. However, the duration of ROSC and the duration without blood flow in the asphyxia group that received CPR at 6 min after CA (Group III) was significantly longer than in the asphyxia group that received CPR at 4 min after CA (Group II; Table II ). In addition, it was found that anal temperature was lower in the two asphyxia groups when compared with the control group. In addition, the rectal temperature in Group III was lower than that in Group II at five consecutive time points (from 10-120 min), but not at 180 min after ROSC (Fig. 1A) .
Subsequently, it was determined whether the various neural defects were present in the asphyxia models. As shown in Fig. 1B , the NDS score was significantly lower in Group III than in Group II at 24, 48 and 72 h after CPR. Additionally, the S100B serum concentration of Group II and III was significantly greater than that in Group I at 72 h after CPR (Fig. 1C) . The immunohistochemistry results indicated that cell morphology in the cerebral cortex was normal in the control (Group I; Fig. 1D ). By contrast, morphological damage was observed in the cerebral cortex of Group II, including a vacuole and swelling in the cytoplasm (Fig. 1E) . Further severe damage was observed in Group III, where necrosis was observed in the cells of cerebral cortex (Fig. 1F) . These data demonstrated that increasing duration of CA increased the severity of neural damage in the cerebral cortex and enhanced the incidence of inflammation.
Dynamic expression patterns of NLRP3, ASC and caspase-1 following ROSC. As the observed neural defects were associated with inflammation, whether the expression levels of certain key inflammatory factors were altered following resuscitation in the CA models were investigated. The potential changes in physiological parameters between the control and five asphyxia groups that were resuscitated at different time points after ROSC were detected. No apparent changes in physiological parameters were observed among the six groups, as presented in Table III . Furthermore, no significant difference in duration of asphyxia and resuscitation among the six groups was observed (Table IV) . Whether the expression levels of key components of the inflammasome, including NLRP3, ASC and caspase-1 were altered following ROSC were determined. The expression level of NLRP3 was constantly demonstrated to increase at different time points, except for 48 h after ROSC ( Fig. 2A and B) . In addition, it was found that the expression level of ASC significantly increased at 6 h after ROSC, but did not exhibit any subsequent further increase ( Fig. 2A and C) . The expression level of caspase-1 increased at 6 and 48 h after ROSC, but showed no further increase at 12, 24 or 72 h after ROSC compared with the previous time points ( Fig. 2A and  D) . These findings were confirmed by immunohistochemical analysis. The number of ASC, NLRP3 and caspase-1 positive cells significantly increased at different time points after ROSC, compared with what was observed in the control (Fig. 3A) . Collectively, these results indicate that the expression levels of NLRP3, ASC and caspase-1 increase with increasing time following ROSC, further enhancing inflammation.
Concentrations of IL-1β and IL-18 increased in the cerebral cortex after ROSC.
ELISA assays were performed to determine whether the concentrations of IL-1β and IL-18 in the cerebral cortex increased after ROSC. Compared with the control group, the concentration of IL-1β was significantly higher at 6 h and reached the maximal level at 12 h after ROSC (Fig. 3B) . The concentration of IL-1β concentration gradually decreased at 24, 48 and 72 h after ROSC, but continued to be higher than that of the control group (Fig. 3B) . Similarly, the IL-18 concentration was significantly higher after 6 h, and consistently increased with increasing time after ROSC (Fig. 3C) . These data demonstrated that IL-1β and IL-18 concentrations were elevated in CA rat models after ROSC, indicating the aggravation of inflammation in the cerebral cortex.
SH alleviated neurological deficiency, apoptosis and inflammation in the CA rat model. Subsequently, the effects of SH on the neurological deficiency and inflammation observed in CA models were elucidated. No significant differences in physiological parameters were observed between the control, SH and CN groups (Table V) . In the CA models, no apparent alteration in asphyxia time and CPR to ROSC time was identified, nor was any change observed in the tested physiological parameters among all four asphyxia groups following ROSC, as presented in Table VI . By contrast, the rectal temperature was significantly lower in the SH group than in the CN group (Fig. 4A) . The NDS score was significantly higher in the SH group compared with the CN group at 24 and 48 h after ROSC (Fig. 4B) . Additionally, the S100B concentration was shown to be reduced in the SH group compared with the CN group at 24 and 48 h after ROSC (Fig. 4C) . Western blot analysis demonstrated that the expression levels of NLRP3, ASC, caspase-1 and caspase-3 markedly decreased in the SH groups compared with the CN group (Fig. 4D-H) . Similar results were obtained via immunohistochemical analysis. The number of NLRP3, ASC, caspase-1 and caspase-3 positive cells in the SH group significantly decreased compared with the CN group (Fig. 5A ). In addition, apoptosis was partially inhibited in the SH group, as the ratio of TUNEL-positive cells in this group was markedly reduced when compared with the CN group, while there was a limited number of apoptotic cells in the control group (Fig. 5B) . Furthermore, SH after ROSC markedly decreased the concentrations of IL-1β and IL-18 (Fig. 5C) . Finally, the cells in the cerebral cortex exhibited more severe damage in the CN group than did the cells in the SH group, while the cell morphology in the control group was normal (Fig. 5D) . Thus, these data demonstrate that SH alleviated neural defects, apoptosis, and inflammation in the cerebral cortex, when compared with the CN group.
Discussion
The present study demonstrates that the expression levels of inflammasome components changed in CA rat models following ROSC, potentially indicating the participation of the inflammasome in post-CA syndrome. In addition, it was found that spontaneous hypothermia mitigated the neural defects and inflammation induced by CPR and ROSC in CA models compared with the CN model, providing mechanistic exploration of the effect of SH on post-CA syndrome and its potential correlation with the inflammasome.
Hypothermia is common in patients with neurologic disorders and those in a critical condition. In the present study, hypothermia was demonstrated in the established CA rat models. This is consistent with previous findings showing that rats resuscitated from asphyxial CA developed mild to moderate hypothermia (21) . An important factor leading to hypothermia is the duration of the perfusion without blood flow. It was identified that a longer duration of asphyxia prior to resuscitation caused a lower body temperature and thus a more serious neural deficit. Hypothermia is a double-edged sword, however, as SH exerted a protective effect against neurologic damage and inflammation in the CA models. Until now, hypothermia has only been a validated effective treatment for brain resuscitation following CA. There is no consensus on the specific duration of hypothermia in the treatment, but the generally accepted time is 12-24 h (24,25). Theoretically, longer durations of hypothermia are more beneficial to the neural tissues. However, there are side effects during the treatment, such as prolonged clotting time and pulmonary infection. Consistent with the current finding in rat models, Vijlbrief et al (26) identified that hypothermia following perinatal asphyxia exerted a beneficial effect on cardiac function in infants, indicating its potential clinical application.
CA induced increased expression levels of pro-inflammatory cytokines, therefore, aggravating the inflammatory reaction. In the hypothermia treatment, however, expression levels of inflammation-associated components are altered. Callaway et al (27) identified that SH alleviated the NDS in CA models, but concluded that altering the inflammatory response subsequent to CA is not necessary to achieve the beneficial effects of hypothermia (27) . By contrast, NLRP3 expression was demonstrated to be lower in the SH group compared with the CN group, and the secretion of IL-18 and IL-1β was decreased in the SH group. This discrepancy is likely due to the different techniques used to initiate the asphyxia and trigger the activation of the NLRP3 inflammasome. Activation of the NLRP3 inflammasome depends on an increase in ATP provision and calcium load, while hypothermia may inhibit the calcium influx and upload (28) . Therefore, SH following resuscitation may work via the above-mentioned mechanisms to inhibit the NLRP3 inflammasome, and potentially downstream IL-18 and IL-1β expression, to exert a neuroprotective effect. However, the specific mechanisms involved require further investigation.
Cell death or apoptosis occurs following ischemia or reperfusion. Previous reports have indicated that hypothermia inhibits caspase-3 mRNA expression (29) . In the caspase family, caspase-1 participates in the inflammatory reaction and is responsible for the activation of pro-inflammatory cytokines, while caspase-3 mediates apoptosis (30) . In the present study, CA caused upregulation of the expression level of caspase-1 and caspase-3; further demonstrating that inflammation and apoptosis were promoted by CA. The initiation of apoptosis occurs subsequent to inflammation. There is, therefore, enough time to intervene before CA induces apoptosis. Various types of treatments such as hypothermia may inhibit apoptosis via caspase-3 inhibition. The current study identified 's t-test) . SH, spontaneous hypothermia; CN, controlled normothermia; S100B, S100 calcium-binding protein B; NLRP3, NACHT, LRR, and PYD domains-containing protein 3; ASC, apoptosis-associated speck-like protein containing a CARD. that expression levels of caspase-1 and caspase-3 decreased with SH in CA models. This result was similar to that observed in the hippocampus, where caspase-1 and caspase-3 expression increased following asphyxia. In recent years, combination therapy has been used to ameliorate neural disorders (31) . Therefore, the present study provides solid evidence to support the potential clinical application of hypothermia. Future investigations will focus on survival prognosis, in order to determine whether hypothermia completely replaces the standard treatment for CA-induced neurologic deficits.
In conclusion, the present study demonstrates that SH ameliorated inflammation and neurologic deficit in CA models following resuscitation. The findings are important to increase understanding of the underlying mechanisms in CA-induced inflammation and neurologic damage following ROSC. Furthermore, the current findings promote a potential novel therapeutic strategy, which may be a promising candidate for increasing the survival rate and quality of life for patients suffering from post-CA syndrome.
